NCT05241782

Brief Summary

Heart rate variability (HRV) in post-stroke patients are closely related to patient mortality, neurological deterioration and overall prognosis. Anxiety and depression will demotivate the patients' will to undergo rehabilitation program, which would delay their functional recovery. The influence of acupressure over the auricle on the HRV, anxiousness and depressive mood have yet to be verified. The investigators aimed to study the effect on auricular acupressure treatment between the different trending of HRV, anxiety and depression and their correlations. This is a randomized control study, consisted of 70 patients with post-stroke depressive mood, from both CGH and Xizhi Cathay hospital in Taiwan. HRV analysis is performed on the first 24 hours, and on a weekly basis for a total of 6 weeks. The included depressed patients were defined by the "Hospital Anxiety and Depression Scale" and weekly will be undertaken by the patients. A "Taiwanese Depression Questionnaire" pre-test and after-test will be undertaken by the patients. Experimental group will receive acupressure treatment by the second week, trice daily, 3\~5minutes each session for a course of four weeks. Data were analyzed using SPSS 20.0, using generalized estimating equation, GEE. The study hypothesized that the auricular acupressure treatment would improve post-stroke depression. Therefore, participants would be more willing to receive rehabilitation program. Our study would also help to provide future references on related studies.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 14, 2021

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

January 26, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

February 16, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 13, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 13, 2022

Completed
Last Updated

February 16, 2022

Status Verified

February 1, 2022

Enrollment Period

12 months

First QC Date

January 26, 2022

Last Update Submit

February 5, 2022

Conditions

Keywords

strokeheart rate variabilityautonomic nerveauricular acupressuredepressionanxiety

Outcome Measures

Primary Outcomes (2)

  • Taiwanese Depression Questionnaire

    The Taiwanese Depression Questionnaire(TDQ), which is a 4-point scale with 18 items, is a culturally specific depression self-rating instrument for effective screening of depression in Taiwan and has satisfactory reliability and validity. Subjects are guided to rate each item on a scale from 0 to 3 on the basis of "how often you felt the physical and emotional aspects during the past week". TDQ scores range from 0 to 54. The original test authors defined three ranges for both of the scales: 0-13 (non-cases), 14-18 (doubtful cases), and 19-54(cases). The higher the score, the more severe the depression.The Taiwanese Depression Questionnaire(TDQ) had a sensitivity of 0.89 and a specificity of 0.92 .

    4 Weeks

  • Hospital Anxiety and Depression Scale

    The reliability of the HADS was good, with Cronbach's α coefficients of 0.86 (anxiety), 0.85 (depression), and 0.91 (total scale).The HADS consists of 14 items. Seven of the items indicate anxiety and the remaining seven items indicate depression. Each item had been answered by the patient on a four point (0-3) response category so the possible scores ranged from 0 to 21 for anxiety and 0 to 21 for depression. The original test authors defined three ranges for both of the scales: 0-7 (non-cases), 8-10 (doubtful cases), and 11-21(cases). It is possible to calculate a HADS total score by simply summing up the anxiety and depression items.

    4 Weeks

Secondary Outcomes (1)

  • Heart rate variability (HRV)

    4 weeks

Study Arms (2)

Experimental group

EXPERIMENTAL

Experimental group will receive acupressure treatment by the second week, trice daily, 3\~5minutes each session for a course of four weeks.

Other: auricular acupressure

Control group

NO INTERVENTION

Experimental group will receive routine care for a course of four weeks.

Interventions

Auricular therapy, as defined by Oleson, refers to "a healthcare modality by stimulating the external surface of the ear to alleviate pathological conditions in other parts of the body"Experimental group will receive acupressure treatment by the second week, trice daily, 3\~5minutes each session for a course of four weeks

Experimental group

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • over 20 years old
  • Within 24 hours of arriving at the hospital with the first symptoms of stroke
  • Hemorrhagic stroke:nontraumatic hemorrhagic stroke and Intracerebral Hemorrhage score 0-1
  • Infarct stroke:National Institutes of Health Stroke Scale less than 30
  • Able to express themselves through oral or written communication
  • Hospital Anxiety and Depression Scale Score equal to or greater than 11

You may not qualify if:

  • Previous diagnosis of arrhythmia
  • Mental illness, dementia, Alzheimer's disease, or possible complete paralysis on imaging
  • Subarachnoid hemorrhage, subdural hemorrhage, epidural hemorrhage
  • Patients with acute myocardial infarction
  • There is a wound or lesion at the ear auricular point

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cathay General Hospital

Taipei, 106, Taiwan

RECRUITING

MeSH Terms

Conditions

StrokeDepressionAnxiety Disorders

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesBehavioral SymptomsBehaviorMental Disorders

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 26, 2022

First Posted

February 16, 2022

Study Start

May 14, 2021

Primary Completion

May 13, 2022

Study Completion

August 13, 2022

Last Updated

February 16, 2022

Record last verified: 2022-02

Locations